MEDI-547 regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for AstraZeneca's MEDI-547 to treat ovarian cancer. The fully human mAb targeting EPH ...